| Literature DB >> 17868958 |
Cindy M P Duke1, Casey A Maguire, Michael C Keefer, Howard J Federoff, William J Bowers, Stephen Dewhurst.
Abstract
HSV-1 amplicon vectors elicit strong T-cell responses to encoded antigens but the qualitative nature of these responses is poorly understood. Antigen-specific CD4(+) and CD8(+) T-cell responses to amplicon and adenovirus (rAd5) vectors encoding HIV-1 gp120 were assessed following immunization of mice, by performing intracellular cytokine staining for IFNgamma, IL2 and TNFalpha, following stimulation of splenocytes with a HIV-1 Env peptide pool. The quality of the primary T-cell response to amplicon and rAd5 vectors was strikingly similar, but there were qualitative differences in responses to amplicon vectors that incorporated different promoters upstream of gp120 - suggesting that promoters can significantly influence immune response quality. When prime-boost combinations were studied, a rAd5 prime and amplicon boost elicited the highest T-cell response. Furthermore, protocols that incorporated a rAd5 prime consistently elicited a greater proportion of polyfunctional CD4(+) T-cells-regardless of boost. This suggests that initial priming can shape immune response quality after a boost. Overall, these findings provide insight into effective vector combinations for HIV-1 vaccine development.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17868958 PMCID: PMC2092414 DOI: 10.1016/j.vaccine.2007.08.015
Source DB: PubMed Journal: Vaccine ISSN: 0264-410X Impact factor: 3.641